Abstract
The use of blood and/or bone marrow stem cell transplantation (SCT) grew extensively in the last decade as technological advances led to improved outcomes and wider availability. The first study of SCT costs, however, was not published until 1989. This paper summarizes current knowledge about costs and cost-effectiveness of allogeneic and autologous SCT for leukemias and lymphoma. Methodological issues in cost studies such as types of costs, methods of data collection, and time horizons are discussed, and studies are evaluated with regard to these issues. Considerations specific to economic analyses of SCT are considered, including the potential impact of technological changes, learning curve effects, and inter-institutional differences.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Waters, T., Bennett, C., Pajeau, T. et al. Economic analyses of bone marrow and blood stem cell transplantation for leukemias and lymphoma: what do we know?. Bone Marrow Transplant 21, 641–650 (1998). https://doi.org/10.1038/sj.bmt.1701160
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.bmt.1701160
Keywords
This article is cited by
-
Economic analysis of unrelated allogeneic bone marrow transplantation: results from the randomized clinical trial of T-cell depletion vs unmanipulated grafts for the prevention of graft-versus-host disease
Bone Marrow Transplantation (2005)
-
Do minitransplants have minicosts? A cost comparison between myeloablative and nonmyeloablative allogeneic stem cell transplant in patients with acute myeloid leukemia
Bone Marrow Transplantation (2005)
-
Why aren't we performing more allografts for aggressive non-Hodgkin's lymphoma?
Bone Marrow Transplantation (2003)
-
Cost analysis of HLA-identical sibling and voluntary unrelated allogeneic bone marrow and peripheral blood stem cell transplantation in adults with acute myelocytic leukaemia or acute lymphoblastic leukaemia
Bone Marrow Transplantation (2002)
-
Costs of high-dose chemotherapy and peripheral blood progenitor cell autograft for breast cancer
Bone Marrow Transplantation (2001)